Contravisory Investment Management Has Decreased Its Maximus (MMS) Stake; Sharps Compliance (SMED) Has 1 Sentiment

April 16, 2018 - By Winifred Garcia

MAXIMUS, Inc. (NYSE:MMS) Logo

Contravisory Investment Management Inc decreased Maximus Inc (MMS) stake by 10.97% reported in 2017Q4 SEC filing. Contravisory Investment Management Inc sold 9,338 shares as Maximus Inc (MMS)’s stock declined 8.91%. The Contravisory Investment Management Inc holds 75,815 shares with $5.43M value, down from 85,153 last quarter. Maximus Inc now has $4.45 billion valuation. The stock increased 0.43% or $0.29 during the last trading session, reaching $68.15. About 206,852 shares traded. MAXIMUS, Inc. (NYSE:MMS) has risen 5.08% since April 16, 2017 and is uptrending. It has underperformed by 6.47% the S&P500.

Sharps Compliance Corp (SMED) investors sentiment decreased to 1 in Q4 2017. It’s down -0.57, from 1.57 in 2017Q3. The ratio is negative, as 13 investment managers increased or started new stock positions, while 13 decreased and sold their equity positions in Sharps Compliance Corp. The investment managers in our database reported: 3.87 million shares, down from 4.06 million shares in 2017Q3. Also, the number of investment managers holding Sharps Compliance Corp in top ten stock positions was flat from 0 to 0 for the same number . Sold All: 4 Reduced: 9 Increased: 8 New Position: 5.

Goodman Financial Corp holds 1.84% of its portfolio in Sharps Compliance Corp. for 997,355 shares. Quantum Capital Management owns 148,593 shares or 0.15% of their US portfolio. Moreover, Lapides Asset Management Llc has 0.11% invested in the company for 127,700 shares. The Texas-based Ranger Investment Management L.P. has invested 0.11% in the stock. North Star Investment Management Corp., a Illinois-based fund reported 200,250 shares.

Sharps Compliance Corp. provides medical, pharmaceutical, and hazardous waste management services in the United States. The company has market cap of $73.17 million. It offers Sharps Recovery System for the containment, transportation, treatment, and tracking of medical waste and used healthcare materials generated outside the hospital and health care facility settings; TakeAway Medication Recovery System, a solution that facilitates the proper disposal of unused medications; MedSafe, a solution for the safe collection, transportation, and proper disposal of unwanted and expired prescription medications; and ComplianceTRAC, a Web compliance and training program. It has a 568.75 P/E ratio. The firm also provides Route-Based Pickup Service, a waste management service, which offers medical and hazardous waste pick-up services; TakeAway Recycle System, a solution for the collection and recycling of single-use medical devices from surgical centers and other healthcare facilities; and Universal Waste Shipback Systems, a solution for the collection, transportation, and recycling of light bulbs, batteries, and other mercury containing devices.

The stock decreased 0.22% or $0.01 during the last trading session, reaching $4.55. About 6,412 shares traded. Sharps Compliance Corp. (SMED) has declined 7.71% since April 16, 2017 and is downtrending. It has underperformed by 19.26% the S&P500.

Since December 15, 2017, it had 0 insider buys, and 4 insider sales for $2.53 million activity. Another trade for 1,000 shares valued at $66,550 was sold by BELIVEAU RUSSELL A. $2.04 million worth of stock was sold by MONTONI RICHARD A on Tuesday, February 20. On Friday, December 15 Andrekovich Mark sold $194,400 worth of MAXIMUS, Inc. (NYSE:MMS) or 2,700 shares. Shares for $232,200 were sold by FRANCIS DAVID.

Investors sentiment decreased to 1.1 in Q4 2017. Its down 0.29, from 1.39 in 2017Q3. It worsened, as 22 investors sold MMS shares while 101 reduced holdings. 46 funds opened positions while 89 raised stakes. 58.07 million shares or 1.27% more from 57.34 million shares in 2017Q3 were reported. Amer International has 176,692 shares. Essex Investment Management Communication Limited Com owns 0.06% invested in MAXIMUS, Inc. (NYSE:MMS) for 6,366 shares. Fdx Advsr reported 3,622 shares or 0.01% of all its holdings. Alta Cap Mgmt Limited Co stated it has 587,844 shares. Metropolitan Life Insur New York invested in 36,933 shares. Smithfield stated it has 0.02% in MAXIMUS, Inc. (NYSE:MMS). The California-based Los Angeles Management And Equity Research has invested 0% in MAXIMUS, Inc. (NYSE:MMS). Advantus Mngmt Inc owns 0.01% invested in MAXIMUS, Inc. (NYSE:MMS) for 8,022 shares. Wealthtrust accumulated 379 shares. Telemus Limited Liability Co reported 176 shares. Blair William & Company Il invested in 0.01% or 10,521 shares. Mondrian Invest Prtnrs Ltd reported 1.26% of its portfolio in MAXIMUS, Inc. (NYSE:MMS). Alps stated it has 7,407 shares. Ahl Prtn Ltd Liability Partnership holds 112,057 shares or 0.13% of its portfolio. Rice Hall James & Associate Limited Company invested in 0.99% or 350,999 shares.

Among 8 analysts covering MAXIMUS (NYSE:MMS), 1 have Buy rating, 0 Sell and 7 Hold. Therefore 13% are positive. MAXIMUS had 36 analyst reports since August 6, 2015 according to SRatingsIntel. Maxim Group downgraded MAXIMUS, Inc. (NYSE:MMS) on Friday, May 5 to “Hold” rating. The company was initiated on Wednesday, September 16 by Canaccord Genuity. Robert W. Baird maintained it with “Hold” rating and $64.0 target in Monday, October 2 report. The stock of MAXIMUS, Inc. (NYSE:MMS) has “Hold” rating given on Friday, February 9 by Maxim Group. Jefferies downgraded MAXIMUS, Inc. (NYSE:MMS) on Friday, May 5 to “Hold” rating. The firm earned “Buy” rating on Thursday, August 20 by Sidoti. The rating was maintained by Jefferies with “Hold” on Thursday, November 9. The firm has “Hold” rating given on Wednesday, January 3 by Robert W. Baird. Canaccord Genuity maintained it with “Hold” rating and $71.0 target in Wednesday, December 13 report. Sidoti downgraded MAXIMUS, Inc. (NYSE:MMS) on Tuesday, November 15 to “Neutral” rating.

MAXIMUS, Inc. (NYSE:MMS) Institutional Positions Chart

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Posts

>